Literature DB >> 3172646

Prognostic indicators in patients presenting with the nephrotic syndrome.

L P Hunt1, C D Short, N P Mallick.   

Abstract

Clinical data from 246 patients presenting with a nephrotic syndrome and biopsy-proven glomerular disorder were analyzed, using statistical survival techniques, to determine which of several variables (sex, age, plasma creatinine, diastolic blood pressure and 24-hour urinary protein loss) were associated with subsequent end-stage renal failure. The best prediction of outcome could be made at one year (N = 121); then plasma creatinine (P less than 0.001) and heavy proteinuria (P = 0.049) were the best determinants. For a given plasma creatinine level, heavy urinary protein was associated with a worse outcome. The incidence of end-stage renal failure was greatest three to four years from the date edema first developed. Plasma creatinine and urinary protein values, collected four-monthly throughout the study period, were analyzed as time-dependent covariates. A relationship was found between the prevailing risk of renal failure and earlier heavy proteinuria (P less than 0.001). Spontaneous complete remission of proteinuria was associated with a highly favorable outcome (P = 0.001) and normal, or impaired but stable, renal function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3172646     DOI: 10.1038/ki.1988.192

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  ACE inhibitors and proteinuria.

Authors:  R T Gansevoort; D de Zeeuw; P E de Jong
Journal:  Pharm World Sci       Date:  1996-12

2.  Clinical and histopathologic findings in adults with the nephrotic syndrome.

Authors:  W Medawar; A Green; E Campbell; M Carmody; J Donohoe; G Doyle; J J Walshe
Journal:  Ir J Med Sci       Date:  1990-05       Impact factor: 1.568

Review 3.  Renal protection and antihypertensive drugs: current status.

Authors:  A Salvetti; P Mattei; I Sudano
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

4.  Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition.

Authors:  Nicholas Stoycheff; Lesley A Stevens; Christopher H Schmid; Hocine Tighiouart; Julia Lewis; Robert C Atkins; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2009-06-25       Impact factor: 8.860

Review 5.  Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials.

Authors:  Xue Shen; Zhongwen Zhang; Xiaoqian Zhang; Junyu Zhao; Xiaojun Zhou; Qinglei Xu; Hongxia Shang; Jianjun Dong; Lin Liao
Journal:  Lipids Health Dis       Date:  2016-10-12       Impact factor: 3.876

6.  Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy.

Authors:  Fengjuan Tang; Yarong Hao; Xue Zhang; Jian Qin
Journal:  Drug Des Devel Ther       Date:  2017-09-21       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.